Go Deep
Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 15,463 | 86.9 | 17.53 | 0.56 | 387.60 |
| Oct 2026 | 15,621 | 85.6 | 17.27 | 0.56 | 381.80 |
| Oct 2026 | 15,434 | 81.3 | 16.44 | 0.56 | 363.50 |
Gujarat Themis Biosyn Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 437,900,000.0 | 442,330,000.0 | 433,682,000.0 | 423,488,000.0 |
| Net Profit | 110,667,000.0 | 108,912,000.0 | 124,646,000.0 | 142,640,000.0 |
| EPS | 1.0 | 1.0 | 1.1 | 1.3 |
Gujarat Themis Biosyn Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,658,058,000.0 | 1,507,884,000.0 | 1,698,219,000.0 | 1,481,297,000.0 | — |
| Net Profit | 466,815,000.0 | 487,717,000.0 | 591,632,000.0 | 579,688,000.0 | — |
| EPS | 4.3 | 4.5 | 5.4 | 5.3 | — |
Gujarat Themis Biosyn Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 5,034,266,000.0 | 3,013,125,000.0 | 2,211,133,000.0 | 1,663,281,000.0 | — |
| Total Liabilities | 2,156,588,000.0 | 529,306,000.0 | 197,372,000.0 | 171,821,000.0 | — |
| Total Equity | 2,877,678,000.0 | 2,483,819,000.0 | 2,013,761,000.0 | 1,491,460,000.0 | — |
Owes vs Owns
Gujarat Themis Biosyn Limited owed ₹0.43 for every ₹1 it owned in Mar 2026, up from ₹0.10 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.43× | 0.18× | 0.09× | 0.10× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Gujarat Themis Biosyn Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 0.8%Receivables 12.1%Inventory 3.1%Fixed assets (tangible) 81.9%Other assets 2.1%
How it's funded — Mar 2026
Short-term debt 6.3%Long-term debt 25.4%Payables 7.3%Other liabilities 3.8%Shareholders' equity 57.2%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 4.1 | 11.7 | 14.1 | 8.9 |
| Receivables | 60.9 | 31.2 | 27.0 | 17.9 |
| Inventory | 15.4 | 5.0 | 3.3 | 14.6 |
| Fixed assets (tangible) | 412.5 | 225.5 | 136.6 | 62.1 |
| Intangible assets | 0.1 | 0.2 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.9 | 30.9 | 39.7 |
| Other assets | 10.4 | 26.7 | 9.1 | 23.1 |
| Liabilities & equity | ||||
| Short-term debt | 31.8 | 0.3 | 0.0 | 0.0 |
| Long-term debt | 128.1 | 29.6 | 0.0 | 0.0 |
| Payables | 36.7 | 14.6 | 9.9 | 9.5 |
| Other liabilities | 19.1 | 8.4 | 9.8 | 7.6 |
| Shareholders' equity | 287.8 | 248.4 | 201.4 | 149.1 |
| Net tangible assets | 287.7 | 248.2 | 201.4 | 149.1 |
Gujarat Themis Biosyn Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 487,773,000.0 | 910,286,000.0 | 642,131,000.0 | 394,763,000.0 | — |
| Investing Activities | -1,722,765,000.0 | -1,118,182,000.0 | -552,119,000.0 | -204,076,000.0 | — |
| Financing Activities | 1,149,268,000.0 | 260,143,000.0 | -85,869,000.0 | -132,746,000.0 | — |